Title |
X-Linked Lymphoproliferative Disease Type 1: A Clinical and Molecular Perspective
|
---|---|
Published in |
Frontiers in immunology, April 2018
|
DOI | 10.3389/fimmu.2018.00666 |
Pubmed ID | |
Authors |
Neelam Panchal, Claire Booth, Jennifer L. Cannons, Pamela L. Schwartzberg |
Abstract |
X-linked lymphoproliferative disease (XLP) was first described in the 1970s as a fatal lymphoproliferative syndrome associated with infection with Epstein-Barr virus (EBV). Features include hemophagocytic lymphohistiocytosis (HLH), lymphomas, and dysgammaglobulinemias. Molecular cloning of the causative gene, SH2D1A, has provided insight into the nature of disease, as well as helped characterize multiple features of normal immune cell function. Although XLP type 1 (XLP1) provides an example of a primary immunodeficiency in which patients have problems clearing primarily one infectious agent, it is clear that XLP1 is also a disease of severe immune dysregulation, even independent of EBV infection. Here, we describe clinical features of XLP1, how molecular and biological studies of the gene product, SAP, and the associated signaling lymphocyte activation molecule family receptors have provided insight into disease pathogenesis including specific immune cell defects, and current therapeutic approaches including the potential use of gene therapy. Together, these studies have helped change the outcome of this once almost uniformly fatal disease. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 1 | 50% |
Unknown | 1 | 50% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 80 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 12 | 15% |
Student > Master | 11 | 14% |
Other | 8 | 10% |
Researcher | 8 | 10% |
Student > Doctoral Student | 5 | 6% |
Other | 15 | 19% |
Unknown | 21 | 26% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 28 | 35% |
Biochemistry, Genetics and Molecular Biology | 9 | 11% |
Immunology and Microbiology | 6 | 8% |
Agricultural and Biological Sciences | 4 | 5% |
Engineering | 4 | 5% |
Other | 5 | 6% |
Unknown | 24 | 30% |